Advanced search
Publication Cover
Postgraduate Medicine Volume 132, 2020 - Issue 4
Submit an article Journal homepage
120
Views
1
CrossRef citations to date
0
Altmetric
Clinical Features - Case Report

Primary hyperparathyroidism associated with non-Hodgkin lymphoma: a case report and literature review

Yuanyuan DengDepartment of Endocrinology, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaView further author information
,
Jiao WangDepartment of Endocrinology, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaView further author information
,
Honghong LiuDepartment of Endocrinology, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaView further author information
,
Jianying LiuDepartment of Endocrinology, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaView further author information
&
Jixiong XuDepartment of Endocrinology, The First Affiliated Hospital of Nanchang University, Jiangxi, ChinaCorrespondenceEmail:[email protected]
View further author information
Pages 398-401 | Received 22 Sep 2019, Accepted 10 Feb 2020, Published online: 20 Feb 2020

References

  • Nilsson IL. Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties. J Intern Med. 2019;285(2):149–164.
  • Bilezikian JP. Primary hyperparathyroidism. Endocr Pract. 2012;18(5):781–790.
  • Seymour IF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non-Hodgkin’s lymphoma. Blood. 1993;82(5):1383–1394.
  • Firkin F, Schneider H, Grill V. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy. Br J Haematol. 1996;94(3):486–492.
  • Maletkovic J, Isorena JP, Palma Diaz MF, et al. Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma. Case Rep Endocrinol. 2014;2014(89):31–34.
  • Strodel WE, Thompson NW, Eckhauser FE, et al. Malignancy and concomitant primary hyperparathyroidism. J Surg Oncol. 2014;37(1):10–12.
  • Luceri PM, Haenel LC IV. A challenging case of hypercalcemia. Thev J Am Osteopathic Assoc. 2013;113(6):490–493.
  • Ogawa T, Kanauchi H, Kammori M, et al. Diffuse large B-cell lymphoma in the thyroid gland associated with primary hyperparathyroidism. Int J Clin Oncol. 2007;12(1):48–51.
  • Owen CM, Blewitt RW, Harrison PV, et al. Two cases of primary hyperparathyroidism associated with primary cutaneous lymphoma. Br J Dermatol. 2000;142(1):120–123.
  • Albes B, Bazex J, Bayle-Lebey P, et al. Primary hyperparathyroidism and cutaneous T-cell lymphoma: fortuitous association? Dermatology. 2001;203(2):162–164.
  • Aguilar-Bernier M, Bassas-Vila J, Bordel-Gomez MT, et al. Lymphomatoid papulosis associated with parathyroid nodular hyperplasia: report of a case. J Eur Acad Dermatol Venereol. 2004;18(6):693–696.
  • Niccoli-Asabellaa A, Ferrari C, Antonica F. et al. Unusual 18F-FDG PET/CT finding of an oxyphil parathyroid adenoma in a patient with Hodgkin’s lymphoma. Rev Esp Med Nucl Imagen Mol. 2014;33(6):370–373.
  • Saha BK, Burns SL, Foulke LA, et al. Rare case of parathyroid gland sarcoidosis presenting with hypercalcaemia. BMJ Case Rep. 2019;12(7):1–3.
  • Bilezikian JP, Potts JT Jr, Gel—H F, et al. Summary statement from a workshop on asymptomatic pri—mary hyperparathyroidism: aperspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):2–11.
  • Bilezikian JP. Ports JT．Asymptomatic primary hyperparathyroidism: newissues and new questions～bridging the past with the future. J Bone Miner Res. 2002;17(2):57–67.
  • Niitsu N. Current treatment strategy of diffuse large B-celllymphomas. Int J Hematol. 2010;92(2):231–237.
  • Hewison M, Kantorovich V, Liker HR, et al. Vitamin Dmediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res. 2003;18(3):579–582.
  • Zhu CY, Nguyen DT, Yeh MW. Who benefits from treatment of primary hyperparathyroidism? Surg Clin North Am. 2019;99(4):667–679.
  • Coiffier B, Sarkoz C. Diffuse large B-cell lymphoma: R-CHOP failure-what to do? Hematology Am Soc Hematol Educ Program. 2016;2016(1):366–378.
  • Morrison VA, Shou Y, Bell JA, et al. Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA. Future Oncol. 2019;15(9):1021–1034.
  • Abadi U, Peled L, Gurion R, et al. Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leuk Lymphoma. 2019;6:1–5.
  • Palmieri S, Roggero L, Cairoli E, et al. Occurrence of malignant neoplasia in patients with primary hyperparathyroidism. Eur J Intern Med. 2017;43:77–82.
  • Pickard AL, Gridley G, Mellemkjae L, et al. Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer. 2002;95(8):1167–1611.
  • Alrezk R, Hannah-Shmouni F, Stratakis CA. MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr Relat Cancer. 2017;24(10):195–208.
  • Gallo A, Cuozzo C, Esposito I, et al. Menin uncouples Elk- 1, JunD and c-Jun phosphorylation from MAP kinase activation. Oncogene. 2002;21:6345–6434.
  • McCarty MF. Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses. 2000;54(3):475–482.
  • Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16(2):83–95.
  • Kenan C, Hasan E, Sule T, et al. Dose primary hyperparathyroidism have an association with thyroid papillary cancer? A retrospective cohort study. World J Surg. 2019;43(5):1243–1248.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.